Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease (F-IBDQ)

Rennes University Hospital

Status: Completed

Conditions: Ulcerative Colitis; Crohn's Disease

Treatments: Other: Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ)

Study type: Observational

Funder types: Other

Identifiers

NCT01891214

LOC/12-17 Bouguen F-IBDQ (Other Identifier)

2013-A00144-41

Details and patient eligibility

About

The purpose of the study is to develop a validated French version of the IBDQ in a cohort of patients suffering from Inflammatory bowel diseases, namely Crohn's disease and Ulcerative Colitis.

Full description

Importance of measuring subjective aspects of the patient's health, often referred to as quality of life (QoL), become increasingly recognized and integrated into healthcare. For this purpose, The Inflammatory Bowel Disease Questionnaire (IBDQ) is a widely used questionnaire for QoL assessment specific for patients who suffer from inflammatory bowel diseases. However, the IBDQ was originally developed in a cohort of Canadian patients in English language. Since QoL is impacted by underlying cultural trends, any translation of the IBDQ should be reassessed in relation to its validity, reliability, and sensitivity to detect change in the new language and cultural context. While the linguistic French translation of the original IBDQ has been validated, the French IBDQ has never been tested adequately on a French cohort of patient that we aim to perform.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• men and women ≥ 18 years of age,
• patient with definite diagnosis of UC or CD for at least 6 months

Exclusion criteria

• adults legally protected (under judicial protection, guardianship, or supervision), persons deprived of their liberty
• inability to comprehend or complete the self-administered questionnaire
• psychiatric diagnosis that prevents participation (many pts will have anxiety or depression and should not be excluded)
• stoma
• malignancy

Trial design

100 participants in 1 patient group

Ulcerative Colitis and Crohn's Disease

Treatment:

Other: Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ)